Screener
Chemed CHE Segment Vitas — Implicit Price Concessions
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept che:ImplicitPriceConcessions.
The source filing: Chemed’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000019584-26-000012
| Line item | Medicare | Medicaid | Commercial | Total |
|---|---|---|---|---|
| Continuous care | 16,582 | 551 | 1,000 | 18,133 |
| $398,108 | $15,432 | $11,609 | $425,149 | |
| All other revenue - self-pay, respite care, etc. | 5,578 | |||
| Subtotal | $430,727 | |||
| Medicare cap adjustment | (2,375) | |||
| Implicit price concessions | (5,077) | |||
| Room and board, net | (3,257) | |||
| Net revenue | $420,018 |
Item 1. Financial Statements
FAQ
- What is Chemed's segment vitas — implicit price concessions?
- Chemed (CHE) reported segment vitas — implicit price concessions of $5.08M in Q1 2026.
- How has Chemed's segment vitas — implicit price concessions changed year-over-year?
- Chemed's segment vitas — implicit price concessions increased by 118.9% year-over-year, from $2.32M to $5.08M.
- What is the long-term trend for Chemed's segment vitas — implicit price concessions?
- Over 2 years (2023 to 2025), Chemed's segment vitas — implicit price concessions has grown at a 0.4% compound annual growth rate (CAGR), from $14.2M to $14.3M.
- What does segment vitas — implicit price concessions mean?
- Represents the estimated difference between the gross transaction price and the amount expected to be collected from payers. This metric is a key indicator of revenue realization quality and payer mix dynamics.
Ask your AI about Chemed's segment vitas — implicit price concessions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude